Biodesix Current Deferred Revenue from 2010 to 2025
| BDSX Stock | USD 0.85 0.03 3.66% |
Current Deferred Revenue | First Reported 2019-12-31 | Previous Quarter 676 K | Current Value 678 K | Quarterly Volatility 1.4 M |
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
Biodesix | Current Deferred Revenue |
Latest Biodesix's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Biodesix over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Biodesix's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Biodesix Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 881,212 | |
| Geometric Mean | 697,237 | |
| Coefficient Of Variation | 92.07 | |
| Mean Deviation | 532,917 | |
| Median | 492,000 | |
| Standard Deviation | 811,350 | |
| Sample Variance | 658.3B | |
| Range | 3.2M | |
| R-Value | 0.35 | |
| Mean Square Error | 620.7B | |
| R-Squared | 0.12 | |
| Significance | 0.19 | |
| Slope | 59,022 | |
| Total Sum of Squares | 9.9T |
Biodesix Current Deferred Revenue History
About Biodesix Financial Statements
Biodesix investors use historical fundamental indicators, such as Biodesix's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 678 K | 1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.